Common Fund Programs with Open Funding Opportunities
Expand All to search section using Ctrl+F |
Expand All
Common Fund Data Ecosystem
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) | 4/4/2024 | RFA-RM-24-006 | George Papanicolaou Anthony Kirilusha | 6/27/2024 |
Somatic Cell Genome Editing (SCGE)
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed) | March 22, 2024 | RFA-RM-24-007 | Betty Poon, Ph.D., poonb@mail.nih.gov | LOI Due Date: Application Receipt Date: |
Venture Program: Oculomics Initiative
| Title | Release Date | Funding Announcement Number | Common Fund Contact | LOI Due Date (Required) | Application Receipt Date |
|---|---|---|---|---|---|
| Development and Application of Ophthalmic Imaging Technologies to Advance our Understanding of Systemic Diseases Research Opportunity Announcement | 3/11/2024 | OTA-24-006 | Tony D. Gover Mary Ann Wu | 4/16/2024 | 5/27/2024 |
Venture Program: SysBio Initiative
| Title | Release Date | Funding Announcement Number | Common Fund Contact | LOI Due Date | Application Receipt Date |
|---|---|---|---|---|---|
| Systems Biology Data Platform Leveraging the Accelerating Medicines Partnership (OT2) | 3/13/2024 | OTA-24-008 | Anthony Kirilusha Erna Petrich | 4/3/2024 | 5/15/2024 |
High-Risk Research: NIH Director's Early Independence Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| NIH Director’s Early Independence Awards (DP5 Clinical Trial Optional) | 3/19/2024 | RFA-RM-24-005 | Becky Miller earlyindependence@mail.nih.gov 301-594-9979 | 9/6/2024 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-23-189 | Becky Miller earlyindependence@mail.nih.gov 301-594-9979 |
High-Risk Research: NIH Director's New Innovator Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional) | 3/19/2024 | RFA-RM-24-003 | Patricia (Trish) Labosky NewInnovatorAward@mail.nih.gov | 8/19/2024 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-23-189 | Patricia (Trish) Labosky NewInnovatorAward@mail.nih.gov |
High-Risk Research: NIH Director's Pioneer Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional) | 3/21/2024 | RFA-RM-24-002 | Patricia (Trish) Labosky PioneerAwards@mail.nih.gov | 9/9/2024 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-23-189 | Patricia (Trish) Labosky PioneerAwards@mail.nih.gov |
High-Risk Research: NIH Director's Transformative Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional) | 3/19/2024 | RFA-RM-24-004 | Patricia (Trish) Labosky Transformative_Awards@mail.nih.gov | 9/3/2024 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-23-189 | Patricia (Trish) Labosky Transformative_Awards@mail.nih.gov |
